Survivin is widely studied in cancer research due to its overexpression in various tumors, such as breast cancer, lung cancer, and colorectal cancer. Its role in promoting cell proliferation and inhibiting apoptosis makes it a potential target for cancer therapy. By understanding survivin's function and expression patterns, researchers can develop targeted therapies that may inhibit its activity, thereby enhancing the effectiveness of conventional treatments.
